EMERGENT BIOSOLUTIONS INC (EBS)       12  +0.19 (+1.61%)

12  +0.19 (+1.61%)

US29089Q1058 - Common Stock - After market: 11.95 -0.05 (-0.42%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
1.51B1.79B1.56B1.11B782.40M
Non Recurring Items
N/A-83.20M-46.30MN/AN/A
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
687.20M716.00M506.70M433.50M322.30M
Gross Profit
826.20M1.08B1.05B672.50M460.10M
Operating Expenses
614.70M640.90M568.60M558.40M370.30M
Operating Income
211.50M435.80M480.10M114.10M89.80M
Interest Expense
-33.50M-34.50M-31.30M-38.40M-9.90M
Income Before Taxes
117.00M314.40M407.20M77.40M81.50M
Income Tax
63.50M83.50M102.10M22.90M23.10M
Net Income
53.50M230.90M305.10M54.50M62.70M
EBITDA
348.40M559.60M594.60M224.80M152.00M
 
Per Share Data
EPS Diluted Total Ops
0.824.275.671.041.22
Non GAAP EPS
2.556.007.852.772.34
 
Statistics
Gross Profit Margin
54.59%60.06%67.42%60.80%58.81%
Profit Margin
3.54%12.88%19.62%4.93%8.01%
Operating Profit Margin
13.98%24.31%30.87%10.32%11.48%

All data in USD

Charts